Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Mant

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
BMJ Open|October 6, 2018
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trialJames P Sheppard, Jenni Burt, Mark Lown, et al.
BMC Cardiovascular Disorders|December 20, 2024
A service evaluation of the implementation of a novel digital intervention for hypertension self-monitoring and management system in primary care (SHIP): protocol for a mixed methods studyAnne Smith, Katherine L Tucker, Rebecca K Barnes, et al.
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
JAMA|May 27, 2020
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical TrialJames P Sheppard, Jenni Burt, Mark Lown, et al.
Journal of the American Geriatrics Society|September 8, 2020
Generalizability of Blood Pressure Lowering Trials to Older Patients: Cross-Sectional AnalysisJames P Sheppard, Mark Lown, Jenni Burt, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Scientific Reports|April 27, 2021
The feasibility of the PAM intervention to support treatment-adherence in people with hypertension in primary care: a randomised clinical controlled trialAikaterini Kassavou, Venus Mirzaei, Sonia Shpendi, et al.
BMC Medical Research Methodology|October 18, 2021
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trialsLisa J Woodhouse, Alan A Montgomery, Jonathan Mant, et al.
BMJ Open|September 12, 2025
Randomised controlled trial to measure effectiveness and cost-effectiveness of a digital social intervention promoted by primary care clinicians to adults with asthma to improve asthma control: protocolGeorgios Dimitrios Karampatakis, Helen E Wood, Chris J Griffiths, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
The Lancet. Healthy Longevity|August 2, 2024
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trialJames P Sheppard, Eleanor Temple, Ariel Wang, et al.
BMJ Open|October 6, 2018
OPtimising Treatment for MIld Systolic hypertension in the Elderly (OPTiMISE): protocol for a randomised controlled non-inferiority trialJames P Sheppard, Jenni Burt, Mark Lown, et al.
BMC Cardiovascular Disorders|December 20, 2024
A service evaluation of the implementation of a novel digital intervention for hypertension self-monitoring and management system in primary care (SHIP): protocol for a mixed methods studyAnne Smith, Katherine L Tucker, Rebecca K Barnes, et al.
JAMA Internal Medicine|September 6, 2017
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysisRakesh Malhotra, Hoang Anh Nguyen, Oscar Benavente, et al.
JAMA|May 27, 2020
Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical TrialJames P Sheppard, Jenni Burt, Mark Lown, et al.
Journal of the American Geriatrics Society|September 8, 2020
Generalizability of Blood Pressure Lowering Trials to Older Patients: Cross-Sectional AnalysisJames P Sheppard, Mark Lown, Jenni Burt, et al.
JAMA|August 27, 2014
Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trialRichard J McManus, Jonathan Mant, M Sayeed Haque, et al.
Scientific Reports|April 27, 2021
The feasibility of the PAM intervention to support treatment-adherence in people with hypertension in primary care: a randomised clinical controlled trialAikaterini Kassavou, Venus Mirzaei, Sonia Shpendi, et al.
BMC Medical Research Methodology|October 18, 2021
Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trialsLisa J Woodhouse, Alan A Montgomery, Jonathan Mant, et al.
BMJ Open|September 12, 2025
Randomised controlled trial to measure effectiveness and cost-effectiveness of a digital social intervention promoted by primary care clinicians to adults with asthma to improve asthma control: protocolGeorgios Dimitrios Karampatakis, Helen E Wood, Chris J Griffiths, et al.
Pageof 25